user

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding:: a report by the Israeli Multidisciplinary rFVIIa task

被引：4
|
作者：
Ariëns, RAS [1 ]
机构：
[1] Univ Leeds, LIGHT, Acad Mol Vasc Med, Leeds LS2 9JT, W Yorkshire, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 04期
关键词：
D O I：
10.1111/j.1538-7836.2005.01263.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：649 / 650
页数：2
相关论文
共 50 条
  • [31] Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa
    Yilmaz, Ali Abbas
    Yalcin, Saban
    Serdaroglu, Hacer
    Sonmezer, Murat
    Uysalel, Asuman
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (07) : 693 - 695
  • [32] Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia
    Poon, Man-Chiu
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (05) : 655 - 664
  • [33] Recombinant activated factor VIIA (RFVIIA)use in children.
    Alten, Jeffrey A.
    Benner, Kim W.
    Green, Kelsey
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : A201 - A201
  • [34] Hemostasis in severe postpartum hemorrhage - The effect of recombinant activated factor VII (RFVIIA)
    Segal, S
    Shemesh, IY
    Yoffe, B
    Laufer, N
    Mankuta, D
    Mazor, M
    Zohar, S
    Shiff, E
    Ben-Tal, O
    Pauzner, D
    Martinowitz, U
    [J]. THROMBOSIS RESEARCH, 2005, 115 : 141 - 141
  • [35] Recombinant activated factor VII (rFVIIa): From concept to clinical utility - Preface
    Mammen, EF
    Michiels, JJ
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04): : 361 - 362
  • [36] Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven®) in obstetrical haemorrhagic shock
    S Sobieszczyk
    GH Breborowicz
    B Kubiaczyk
    T Opala
    [J]. Critical Care, 7 (Suppl 2):
  • [37] Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII
    Liebman, HA
    Chediak, J
    Fink, KI
    Galvez, AG
    Shah, PC
    Sham, RL
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2000, 63 (03) : 109 - 113
  • [38] Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban
    Stepinska, J
    Banaszewski, M
    Konopka, A
    Szajewski, T
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 87 (02) : 355 - 356
  • [39] Recombinant Activated Factor VII (rFVIIa) for Bleeding After Thoracic Aortic Surgery: A Scoping Review of Current Literature
    Navarro, Ryan
    Bojic, Sandra
    Fatima, Rubab
    El-Tahan, Mohamed
    El-Diasty, Mohammad
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (01) : 275 - 284
  • [40] Recombinant activated factor VII (rFVIIa-NovoSeven®-NovoNordisk) treatment of bleeding complications in intensive care unit
    A Bonadona
    P Pavese
    R Hamidfar
    G Pernod
    T Stouls
    C Pison
    C Letoublon
    D Barnoud
    [J]. Critical Care, 6 (Suppl 1):
12345